Previous Close | 39.30 |
Open | 40.34 |
Bid | 38.16 x 100 |
Ask | 38.50 x 100 |
Day's Range | 38.05 - 42.12 |
52 Week Range | 26.61 - 69.87 |
Volume | |
Avg. Volume | 674,530 |
Market Cap | 2.193B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Septerna upped the size of its offering twice before pricing a stock sale that raised funds for its lead candidate, a treatment for hypoparathyroidism now in Phase 1 testing.
We recently published a list of 10 Biggest Stocks with Negative Beta to Consider. In this article, we are going to take a look at where Structure Therapeutics (NASDAQ:GPCR) stands against other biggest stocks with negative beta to consider. Beta is a measureament of market risk or volatility that indicates how much the price of […]